20/20 Biolabs, Inc. Share Price

20/20 Biolabs, Inc. Share Price

NASDAQ: AIDX
$0.00
-$0.22 (--%)
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

20/20 Biolabs, Inc. Stock Performance

Open
N/A
Prev. Close
$0.22
Circuit Range
N/A
Day Range
N/A
Year Range
$0.19 - $20.52
Volume
N/A
Average Traded
N/A

20/20 Biolabs, Inc. Share Price Chart

Line chart of the 20/20 Biolabs, Inc. price trend over the selected period. The price fell overall, ranging from 0.21 to 0.22, ending at 0.22.
$0.00$0.00
L
Show Current Price
H

20/20 Biolabs, Inc. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
N/A
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

20/20 Biolabs, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2026Jun 2026
Revenue$0.35$0.73
Net Profit-$2.12-$2.75
Net Profit Margin-605.71%-376.71%
Income ChangeN/A-29.72%

About 20/20 Biolabs, Inc.

20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.

20/20 Biolabs, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.22
$0.22
+5.69%
Oct 2026
$0.42
$0.21
-49.16%
Sep 2026
$0.56
$0.41
-33.06%
Aug 2026
$0.47
$0.62
+44.52%
Jul 2026
$0.59
$0.43
-21.86%
Jun 2026
$0.93
$0.55
-36.53%
May 2026
$1.60
$0.86
-43.09%
Apr 2026
$1.86
$1.52
-11.11%
Mar 2026
$3.53
$1.71
-52.17%
Feb 2026
$20.52
$3.58
N/A

AIDX Share Price FAQs